amiodarone has been researched along with Cardiomyopathy, Dilated in 107 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Cardiomyopathy, Dilated: A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate the long-term effect of combined intermittent dobutamine infusions (IDI) and oral amiodarone on reverse left ventricular (LV) remodeling and hemodynamics of patients with idiopathic dilated cardiomyopathy (IDC) and end-stage congestive heart failure (CHF)." | 9.12 | Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy. ( Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ, 2006) |
| "Minimally invasive video-assisted thyroidectomy under regional anesthesia can be proposed as resolution of amiodarone-induced thyrotoxicosis in high risk patients with severe cardiac disorders, after preparation with iopanoic acid." | 7.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Among the amiodarone-induced thyroid dysfunctions, thyrotoxicosis is the most troublesome and with the highest rate of morbidity and mortality." | 7.73 | [Use of lithium carbonate for the treatment of amiodarone-induced thyrotoxicosis]. ( Boeving, A; Carvalho, GA; Cubas, ER; Graf, H; Santos, CM, 2005) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 7.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "For a patient with idiopathic dilated cardiomyopathy, an implantable defibrillator, and amiodarone induced thyrotoxicosis associated with ventricular fibrillation storm." | 7.71 | Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. ( Manios, EG; Marketou, ME; Simantirakis, EN; Vardas, PE, 2001) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 7.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "Amiodarone treatment was associated with a significant increase in TNF-alpha levels in patients with ischemic cardiomyopathy, 12." | 6.69 | Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Fay, WP; Fisher, SG; Fletcher, RD; Morady, F; Oral, H; Singh, SN, 1999) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 5.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| "We report a case of amiodarone-induced torsade de pointes in a child aged 10 years." | 5.31 | Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy. ( Bevilacqua, M; Drago, F; Ragonese, P; Silvetti, MS, 2001) |
| "A 70-year-old woman with dilated cardiomyopathy and ventricular tachyarrhythmia was initially treated in 1990 with intravenous amiodarone (240 mg)." | 5.31 | Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. ( Kuga, K; Yamada, S; Yamaguchi, I, 2001) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 5.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "Ventricular arrhythmias were present in 62 (95." | 5.27 | Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. ( Camerini, F; Mestroni, L; Neri, R; Pandullo, C; Salvi, A, 1987) |
| "The aim of this study was to evaluate the long-term effect of combined intermittent dobutamine infusions (IDI) and oral amiodarone on reverse left ventricular (LV) remodeling and hemodynamics of patients with idiopathic dilated cardiomyopathy (IDC) and end-stage congestive heart failure (CHF)." | 5.12 | Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy. ( Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ, 2006) |
| " Furthermore, combination of BVP and oral administration of amiodarone significantly prevented recurrence of ventricular tachycardia and paroxysmal atrial fibrillation, and maintained sinus rhythm for a long period." | 5.11 | Effect of biventricular pacing therapy in patients with dilated cardiomyopathy with severe congestive heart failure. ( Baba, H; Goto, K; Kawagoe, J; Noma, M; Origuchi, H; Sakamoto, M; Sese, A; Takemoto, M; Yamamoto, H; Yoshimura, H, 2004) |
| " Randomized clinical trials of prophylactic amiodarone in patients with congestive heart failure and nonsustained ventricular tachycardia have produced conflicting results." | 4.79 | Evaluation and treatment of nonsustained ventricular tachycardia. ( Wilber, DJ, 1996) |
| " In the ICD group, adequate interventions appear mainly in the initial observation period (HR 2,01), in patients with left ventricular hypertrophy (HR 2,98) and ventricular arrhythmias (HR 6,78) and not treated with amiodarone (HR 4,31)." | 3.85 | [Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy]. ( Lelakowska, M; Lelakowski, J; Piekarz, J; Pudło, J; Rydlewska, A, 2017) |
| "Minimally invasive video-assisted thyroidectomy under regional anesthesia can be proposed as resolution of amiodarone-induced thyrotoxicosis in high risk patients with severe cardiac disorders, after preparation with iopanoic acid." | 3.74 | Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study. ( Ambrosini, CE; Berti, P; Bogazzi, F; Martino, E; Materazzi, G; Miccoli, P, 2007) |
| "Two patients presented with atrial fibrillation which was refractory to amiodarone but successfully treated with bepridil." | 3.73 | [Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports]. ( Hadano, Y; Iwami, T; Kimura, M; Matsuzaki, M; Miyazaki, Y; Ogawa, H; Shimizu, A; Takaki, A; Wakeyama, T, 2006) |
| "Among the amiodarone-induced thyroid dysfunctions, thyrotoxicosis is the most troublesome and with the highest rate of morbidity and mortality." | 3.73 | [Use of lithium carbonate for the treatment of amiodarone-induced thyrotoxicosis]. ( Boeving, A; Carvalho, GA; Cubas, ER; Graf, H; Santos, CM, 2005) |
| "This report deals with two cases of amiodarone induced pulmonary toxicity in dilated cardiomyopathy leading to respiratory insufficiency." | 3.71 | [Amiodarone induced pulmonary toxicity]. ( Alter, P; Grimm, W; Maisch, B, 2002) |
| "For a patient with idiopathic dilated cardiomyopathy, an implantable defibrillator, and amiodarone induced thyrotoxicosis associated with ventricular fibrillation storm." | 3.71 | Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice. ( Manios, EG; Marketou, ME; Simantirakis, EN; Vardas, PE, 2001) |
| "The effect of oral amiodarone (AMD) therapy on left ventricular (LV) function was evaluated retrospectively in Japanese patients with ventricular tachyarrhythmias and congestive heart failure." | 3.70 | Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias. ( Yamada, S; Yamaguchi, I, 1998) |
| " 1 and 2, atrial fibrillation was treated with either quinidine or quinidine and sotalol in combination." | 3.69 | Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports. ( Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M, 1994) |
| "Amiodarone treatment in pregnancy might be difficult to handle because of the long half-life of the drug (14-28 days up to 2 months) and because it reduces maternal and neonatal thyroid activity." | 3.68 | Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome. ( Civitella, C; Garzetti, GG; Romanini, C; Valensise, H, 1992) |
| "In 32 subjects, 10 with postischemic dilated cardiomyopathy, 12 with hypertensive cardiomyopathy, and 10 healthy, we assessed QT(c) and QT variability index (QTVI) after administration of fresh pink grapefruit juice, placebo, amiodarone, or sotalol." | 2.73 | Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects. ( Ghiselli, A; Magnanti, M; Magrì, D; Marigliano, V; Matera, S; Mitra, M; Paroli, M; Pasquazzi, E; Piccirillo, G; Schifano, E; Velitti, S, 2008) |
| "Non ischemic dilated cardiomyopathy (NIDCM) is a substrate for sudden cardiac death." | 2.71 | Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications. ( Strickberger, SA; Wijetunga, M, 2003) |
| "Amiodarone treatment was associated with a significant increase in TNF-alpha levels in patients with ischemic cardiomyopathy, 12." | 2.69 | Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. ( Fay, WP; Fisher, SG; Fletcher, RD; Morady, F; Oral, H; Singh, SN, 1999) |
| " In group A no antiarrhythmic drug was administered, while in group B 54/72 patients were treated with amiodarone (mean dosage 300 mg/day) for a mean period of 69." | 2.69 | Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. ( Castelli, G; Cecchi, F; Ciaccheri, M; Dolara, A; Marconi, P; Montereggi, A; Nannini, M; Olivotto, J; Troiani, V, 1999) |
| "Amiodarone was judged effective in 7 patients by both tests (group I) and in 15 by either electrophysiologic study or Holter monitoring (group II)." | 2.68 | [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring]. ( Hosoda, S; Kasanuki, H; Ohnishi, S; Tsuchiya, M, 1996) |
| "Amiodarone has a more favourable therapeutic profile than flecainide and propafenone in these patients, having less tendency to worsen heart failure." | 2.67 | A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). ( , 1992) |
| "Sustained monomorphic ventricular tachycardia was induced with one to two extrastimuli; three extrastimuli only increased the incidence of inducible ventricular fibrillation (8 patients, 28%)." | 2.67 | [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy]. ( Faber, T; Furtwängler, A; Hohnloser, S; Just, H; Meinertz, T; Zehender, M, 1992) |
| "Amiodarone pneumonitis is a serious complication that may lead to fatal lung fibrosis." | 2.67 | Pulmonary clearance of technetium 99m diethylene triamine penta-acetic acid aerosol in patients with amiodarone pneumonitis. ( Camargo, EE; Cukier, A; Meneguetti, JC; Soares Júnior, J; Teixeira, LR; Terra-Filho, M; Vargas, FS, 1990) |
| "Mitral valve prolapse is more frequent in hyperthyroid patients than in normals." | 2.41 | [Hyperthyroidism and heart]. ( Weissel, M, 2001) |
| "VT recurrence was predicted by prior implantable cardioverter-defibrillator shocks, basal anteroseptal VT origin, and procedural failure but not LVEF." | 1.72 | Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia. ( Arya, A; Baldinger, SH; Berruezo, A; Carbucicchio, C; Catto, V; de Riva, M; Deneke, T; Ebert, M; Gaspar, T; Hindricks, G; Kumar, S; Piorkowski, C; Shivkumar, K; Soejima, K; Stevenson, WG; Tedrow, UB; van Rein, N; Vaseghi, M; Wijnmaalen, AP; Zeppenfeld, K, 2022) |
| "Amiodarone, which was initiated for MAT, unexpectedly ameliorated thyrotoxicosis, resulting in a euthyroid state and the patient's significantly improved condition and cardiac function." | 1.62 | Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report. ( Hashimoto, T; Ishibashi-Ueda, H; Monno, S; Ohta-Ogo, K; Yamamoto, H, 2021) |
| "Severe ventricular arrhythmias are frequent during heart failure; they are a life-threatening condition due to the increased risk of sudden death." | 1.46 | [Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)]. ( Ellenga-Mbolla, B; Gombet, TR; Ikama, SM; Kimbally-Kaky, G; Makani, J; Ondze-Kafata, LI, 2017) |
| "Obesity is associated with an increased risk of development of chronic heart failure, but recent epidemiological studies indicate that a higher body mass index (BMI) is associated with a better survival rate." | 1.34 | [Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report]. ( Kawano, S; Kozai, T; Tanaka, H; Urabe, Y, 2007) |
| "A 31-year-old man with dilated cardiomyopathy was hospitalized for new-onset atrial fibrillation." | 1.34 | Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration. ( DeVore, KJ; Hobbs, RA, 2007) |
| "Amiodarone treatment improved left ventricular pressure, central venous pressure, and rate of isovolumetric contraction and decreased ventricular weight (P<0." | 1.33 | Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy. ( Aizawa, Y; Hanawa, H; Hirono, S; Ito, M; Kashimura, T; Kato, K; Kodama, M; Ma, M; Okura, Y; Tachikawa, H; Takahashi, T; Watanabe, K, 2005) |
| "Amiodarone treatment was terminated, and the patient was given corticosteroids." | 1.33 | Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse. ( Kobayashi, N; Kojima, J; Kudo, K; Okayasu, K; Sugiyama, H; Takeda, Y; Yoshizawa, A, 2006) |
| "The diagnosis was interstitial pneumonitis induced by amiodarone." | 1.33 | [Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report]. ( Arakawa, T; Hashimoto, Y; Ichihara, N; Isobe, M; Matsumura, A; Sato, S; Suzuki, M; Yoshikawa, S, 2006) |
| "Amiodarone (200 mg/day) was continuously administered after DC shock to maintain SR." | 1.32 | Simultaneous double external DC shock technique for refractory atrial fibrillation in concomitant heart disease. ( Demircioglu, F; Ersel-Tüzüner, F; Kabukcu, M; Minareci, K; Yanik, E, 2004) |
| "Nonischemic heart disease, especially idiopathic dilated cardiomyopathy, is relatively common among Japanese patients receiving amiodarone for concomitant ventricular arrhythmia, but the hemodynamic effects of amiodarone in these Japanese patients are unclear." | 1.32 | Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study. ( Ishizuka, N; Kasanuki, H; Matsuda, N; Shiga, T; Suzuki, T; Wakaumi, M, 2003) |
| "Amiodarone is a useful drug for the treatment of life-threatening cardiac arrhythmias." | 1.31 | Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity. ( Kawahara, Y; Matsushima, T; Miyashita, N; Nakajima, M; Niki, Y; Yoshida, K, 2000) |
| "Amiodarone was administered after a second episode of ICD discharge." | 1.31 | T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy. ( Adachi, T; Asano, T; Baba, T; Ezumi, H; Katagiri, T; Koba, S; Kobayashi, Y; Matsuyama, T; Miyata, A; Obara, C; Ryu, S; Tanno, K, 2001) |
| "A 70-year-old woman with dilated cardiomyopathy and ventricular tachyarrhythmia was initially treated in 1990 with intravenous amiodarone (240 mg)." | 1.31 | Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy. ( Kuga, K; Yamada, S; Yamaguchi, I, 2001) |
| "We report a case of amiodarone-induced torsade de pointes in a child aged 10 years." | 1.31 | Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy. ( Bevilacqua, M; Drago, F; Ragonese, P; Silvetti, MS, 2001) |
| "All patients suffered from idiopathic dilated cardiomyopathy, were in NYHA functional class II, and the mean left ventricular ejection fraction was 21 +/- 6%." | 1.30 | Amiodarone concentration in human myocardium after rapid intravenous administration. ( Agapitos, E; Alexopoulos, G; Anastasiou-Nana, MI; Karli, JN; Margari, ZJ; Nanas, JN; Patsi, EN; Stamatelopoulos, SF, 1999) |
| "4 months after implantation bursts of ventricular tachycardia recurred every few minutes that responded to renewed amiodarone administration." | 1.30 | [Implantation of a transvenous defibrillation system in isolated persistent left superior vena cava]. ( Kowallik, P; Krein, A; Meesmann, M; Peters, W; Wittenberg, G, 1997) |
| "In severe dilated cardiomyopathy after one year amiodarone treatment there was a significant decrease of heart rate, the new Doppler index and a significant increase of ejection fraction, ejection time and relative diastolic filling time." | 1.30 | [Effect of chronic amiodarone therapy on left ventricular function in dilated cardiomyopathy studied by the new Doppler-index]. ( Lengyel, M, 1998) |
| "We present a case with dilated cardiomyopathy and recurrent sustained monomorphic ventricular tachycardia who received an automatic implantable cardioverter defibrillator (AICD) while under long-term amiodarone treatment." | 1.29 | Is there an effect of amiodarone on the defibrillation threshold? ( Akalin, H; Akyol, T; Bayar, M; Güldal, M; Karaoguz, R, 1993) |
| "A case of severe dilated cardiomyopathy in a young boy presenting with incessant ventricular tachycardia, who had been referred for heart transplantation is reported." | 1.28 | [Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia]. ( Bahia, FC; Gontijo Filho, B; Sternick, EB; Vrandecic, MO, 1992) |
| "Etiology of dilated cardiomyopathy included ischemic heart disease (33%), idiopathic (42%) and miscellaneous (25%)." | 1.28 | Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. ( Baron, DW; Hickie, JB; Keogh, AM, 1990) |
| "Three patients affected by dilated cardiomyopathy complicated by refractory ventricular tachycardia, with a high risk of sudden cardiac death, underwent transcatheter electric fulguration." | 1.28 | [Endocavitary transcatheter electric fulguration as a therapeutic alternative in refractory ventricular tachycardia]. ( Alexidou, G; Ansalone, G; Bisceglie, I; Cacciatore, G; Carelli, M; Di Marcotullio, G; Santini, M; Tubaro, M, 1990) |
| "In all six patients with sudden death or recurrence of VT, the arrhythmia remained inducible on drug therapy." | 1.27 | Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. ( Buxton, AE; Doherty, JU; Josephson, ME; Marchlinski, FE; Poll, DS; Waxman, HL, 1984) |
| "Amiodarone was used in the treatment of 21 patients with supraventricular or ventricular arrhythmias which were refractory to conventional antiarrhythmic drugs, individually or in combination." | 1.27 | Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias. ( Best, JF; Dunn, M; Lynch, L; Rinkenberger, R, 1986) |
| "Digoxin half-life was prolonged." | 1.27 | Digoxin toxicity associated with amiodarone therapy in children. ( Hesslein, PS; Koren, G; MacLeod, SM, 1984) |
| "65 patients with dilated cardiomyopathy underwent 24-hour electrocardiographic monitoring: 95." | 1.27 | [Ambulatory ECG in cardiomyopathies]. ( Camerini, F; Di Lenarda, A; Mestroni, L; Miani, D; Neri, R, 1987) |
| "Ventricular arrhythmias were present in 62 (95." | 1.27 | Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone. ( Camerini, F; Mestroni, L; Neri, R; Pandullo, C; Salvi, A, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (14.95) | 18.7374 |
| 1990's | 30 (28.04) | 18.2507 |
| 2000's | 44 (41.12) | 29.6817 |
| 2010's | 12 (11.21) | 24.3611 |
| 2020's | 5 (4.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, S | 1 |
| Yadav, A | 1 |
| Gupta, A | 1 |
| Zeppenfeld, K | 1 |
| Wijnmaalen, AP | 1 |
| Ebert, M | 1 |
| Baldinger, SH | 1 |
| Berruezo, A | 1 |
| Catto, V | 1 |
| Vaseghi, M | 1 |
| Arya, A | 1 |
| Kumar, S | 1 |
| de Riva, M | 1 |
| Deneke, T | 1 |
| Gaspar, T | 1 |
| Soejima, K | 1 |
| van Rein, N | 1 |
| Tedrow, UB | 1 |
| Piorkowski, C | 1 |
| Shivkumar, K | 1 |
| Carbucicchio, C | 1 |
| Hindricks, G | 1 |
| Stevenson, WG | 3 |
| Dohain, AM | 1 |
| Lotfy, W | 1 |
| Abdelmohsen, G | 1 |
| Sobhy, R | 1 |
| Abdelaziz, O | 1 |
| Elsaadany, M | 1 |
| Abdelsalam, MH | 1 |
| Ibrahim, H | 1 |
| Yamamoto, H | 2 |
| Monno, S | 1 |
| Ohta-Ogo, K | 1 |
| Ishibashi-Ueda, H | 1 |
| Hashimoto, T | 1 |
| Torimitsu, T | 1 |
| Yoshida, T | 1 |
| Nishi, S | 1 |
| Itoh, H | 1 |
| Oya, M | 1 |
| Ikama, SM | 1 |
| Makani, J | 1 |
| Ellenga-Mbolla, B | 1 |
| Ondze-Kafata, LI | 1 |
| Gombet, TR | 1 |
| Kimbally-Kaky, G | 1 |
| Wei, A | 1 |
| Peng, J | 1 |
| Gu, Z | 1 |
| Li, J | 1 |
| Faiella, W | 1 |
| Bessoudo, R | 1 |
| De Maria, E | 1 |
| Patrizi, G | 1 |
| Cappelli, S | 1 |
| Agarwal, AK | 1 |
| Ram, J | 1 |
| Bobbo, M | 1 |
| Pinamonti, B | 1 |
| Merlo, M | 1 |
| Stolfo, D | 1 |
| Iorio, A | 1 |
| Ramani, F | 1 |
| Barbati, G | 1 |
| Carriere, C | 1 |
| Massa, L | 1 |
| Poli, S | 1 |
| Scapol, S | 1 |
| Gigli, M | 1 |
| Di Lenarda, A | 2 |
| Sinagra, G | 1 |
| Lelakowski, J | 1 |
| Rydlewska, A | 1 |
| Lelakowska, M | 1 |
| Pudło, J | 1 |
| Piekarz, J | 1 |
| Dahl, P | 1 |
| Danzi, S | 1 |
| Klein, I | 1 |
| Cadrin-Tourigny, J | 1 |
| Fournier, A | 1 |
| Andelfinger, G | 1 |
| Khairy, P | 1 |
| Basargina, EN | 1 |
| Belova, NR | 1 |
| Hirasawa, Y | 1 |
| Nakagomi, A | 1 |
| Kobayashi, Y | 2 |
| Katoh, T | 1 |
| Mizuno, K | 1 |
| Nakaya, H | 1 |
| Cornette, J | 1 |
| ten Harkel, AD | 1 |
| Steegers, EA | 1 |
| Tsuda, E | 1 |
| Matsuo, M | 1 |
| Sakaguchi, H | 1 |
| Hayashi, T | 1 |
| Hosoda, K | 1 |
| Miyazaki, A | 1 |
| Ross, JJ | 1 |
| Britton, KA | 1 |
| Desai, AS | 1 |
| Jurado Román, A | 1 |
| Rubio Alonso, B | 1 |
| Martín Asenjo, R | 1 |
| Salguero Bodes, R | 1 |
| López Gil, M | 1 |
| Arribas Ynsaurriaga, F | 1 |
| Bunch, TJ | 1 |
| Mahapatra, S | 1 |
| Murdock, D | 1 |
| Molden, J | 1 |
| Weiss, JP | 1 |
| May, HT | 1 |
| Bair, TL | 1 |
| Mader, KM | 1 |
| Crandall, BG | 1 |
| Day, JD | 1 |
| Osborn, JS | 1 |
| Muhlestein, JB | 1 |
| Lappe, DL | 1 |
| Anderson, JL | 1 |
| Vischer, AS | 1 |
| Sticherling, C | 1 |
| Kühne, MS | 1 |
| Osswald, S | 1 |
| Schaer, BA | 1 |
| Grimm, W | 3 |
| Maisch, B | 2 |
| Suzuki, T | 2 |
| Shiga, T | 1 |
| Wakaumi, M | 1 |
| Matsuda, N | 1 |
| Ishizuka, N | 1 |
| Kasanuki, H | 2 |
| Strickberger, SA | 2 |
| Hummel, JD | 1 |
| Bartlett, TG | 1 |
| Frumin, HI | 1 |
| Schuger, CD | 1 |
| Beau, SL | 1 |
| Bitar, C | 1 |
| Morady, F | 2 |
| Jonkaitiene, R | 1 |
| Mizariene, V | 1 |
| MacFadyen, RJ | 1 |
| Palmer, TJ | 1 |
| Hisamuddin, K | 1 |
| Doggrell, SA | 1 |
| Wijetunga, M | 1 |
| Cawley, PJ | 1 |
| Al-Khatib, SM | 1 |
| Takemoto, M | 1 |
| Sakamoto, M | 1 |
| Kawagoe, J | 1 |
| Goto, K | 1 |
| Baba, H | 1 |
| Noma, M | 1 |
| Origuchi, H | 1 |
| Yoshimura, H | 1 |
| Sese, A | 1 |
| Kabukcu, M | 1 |
| Demircioglu, F | 1 |
| Yanik, E | 1 |
| Minareci, K | 1 |
| Ersel-Tüzüner, F | 1 |
| Tachikawa, H | 1 |
| Kodama, M | 1 |
| Watanabe, K | 1 |
| Takahashi, T | 1 |
| Ma, M | 1 |
| Kashimura, T | 1 |
| Ito, M | 1 |
| Hirono, S | 1 |
| Okura, Y | 1 |
| Kato, K | 1 |
| Hanawa, H | 1 |
| Aizawa, Y | 1 |
| Tsagalou, EP | 2 |
| Anastasiou-Nana, MI | 3 |
| Terrovitis, JV | 2 |
| Nanas, SN | 2 |
| Alexopoulos, GP | 2 |
| Kanakakis, J | 2 |
| Nanas, JN | 3 |
| Tsolakis, EJ | 1 |
| Toumanidis, S | 1 |
| Papazoglou, PD | 1 |
| Boeving, A | 1 |
| Cubas, ER | 1 |
| Santos, CM | 1 |
| Carvalho, GA | 1 |
| Graf, H | 1 |
| Schreiber, DH | 1 |
| DeFreest, MS | 1 |
| Yoshikawa, S | 1 |
| Suzuki, M | 1 |
| Ichihara, N | 1 |
| Sato, S | 1 |
| Arakawa, T | 1 |
| Matsumura, A | 1 |
| Hashimoto, Y | 1 |
| Isobe, M | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Bogazzi, F | 1 |
| Ambrosini, CE | 1 |
| Martino, E | 1 |
| Miccoli, P | 1 |
| Karaoguz, R | 2 |
| Maydanozcu, S | 1 |
| Altun, T | 1 |
| Güldal, M | 2 |
| Akyürek, O | 1 |
| Erol, C | 1 |
| Leong-Sit, P | 1 |
| Gula, LJ | 1 |
| Diamantouros, P | 1 |
| Krahn, AD | 1 |
| Skanes, AC | 1 |
| Yee, R | 1 |
| Klein, GJ | 1 |
| Okayasu, K | 1 |
| Takeda, Y | 1 |
| Kojima, J | 1 |
| Yoshizawa, A | 1 |
| Kobayashi, N | 1 |
| Sugiyama, H | 1 |
| Kudo, K | 1 |
| Kimura, M | 1 |
| Ogawa, H | 1 |
| Wakeyama, T | 1 |
| Takaki, A | 1 |
| Iwami, T | 1 |
| Hadano, Y | 1 |
| Miyazaki, Y | 1 |
| Shimizu, A | 1 |
| Matsuzaki, M | 1 |
| DeVore, KJ | 1 |
| Hobbs, RA | 1 |
| Tanaka, H | 1 |
| Kawano, S | 1 |
| Kozai, T | 1 |
| Urabe, Y | 1 |
| Pantos, C | 1 |
| Dritsas, A | 1 |
| Mourouzis, I | 1 |
| Dimopoulos, A | 1 |
| Karatasakis, G | 1 |
| Athanassopoulos, G | 1 |
| Mavrogeni, S | 1 |
| Manginas, A | 1 |
| Cokkinos, DV | 1 |
| Piccirillo, G | 1 |
| Magrì, D | 1 |
| Matera, S | 1 |
| Magnanti, M | 1 |
| Pasquazzi, E | 1 |
| Schifano, E | 1 |
| Velitti, S | 1 |
| Mitra, M | 1 |
| Marigliano, V | 1 |
| Paroli, M | 1 |
| Ghiselli, A | 1 |
| Koren, G | 1 |
| Hesslein, PS | 1 |
| MacLeod, SM | 1 |
| Poll, DS | 1 |
| Marchlinski, FE | 1 |
| Buxton, AE | 1 |
| Doherty, JU | 1 |
| Waxman, HL | 1 |
| Josephson, ME | 1 |
| Terada, Y | 1 |
| Mitsui, T | 1 |
| Yoshimura, Y | 1 |
| Osaka, M | 1 |
| Mihara, W | 1 |
| Djian, J | 1 |
| Faber, TS | 1 |
| Zehender, M | 2 |
| Van de Loo, A | 1 |
| Hohnloser, S | 2 |
| Just, H | 2 |
| Stevenson, LW | 1 |
| Middlekauff, HR | 1 |
| Saxon, LA | 1 |
| Akalin, H | 1 |
| Bayar, M | 1 |
| Akyol, T | 1 |
| Conti, JB | 1 |
| Curtis, AB | 1 |
| Wilber, DJ | 1 |
| Tsuchiya, M | 1 |
| Ohnishi, S | 1 |
| Hosoda, S | 1 |
| Peters, W | 1 |
| Krein, A | 1 |
| Kowallik, P | 1 |
| Wittenberg, G | 1 |
| Meesmann, M | 1 |
| Manolis, AG | 2 |
| Katsivas, A | 1 |
| Lazaris, E | 1 |
| Koutsogeogis, D | 1 |
| Louvros, N | 1 |
| Lazzari, JO | 1 |
| Gonzalez, J | 1 |
| Schuster, MM | 1 |
| Lengyel, M | 1 |
| Yamada, S | 2 |
| Yamaguchi, I | 2 |
| Oral, H | 1 |
| Fisher, SG | 1 |
| Fay, WP | 1 |
| Singh, SN | 1 |
| Fletcher, RD | 1 |
| Castelli, G | 1 |
| Ciaccheri, M | 1 |
| Cecchi, F | 1 |
| Troiani, V | 1 |
| Nannini, M | 1 |
| Marconi, P | 1 |
| Olivotto, J | 1 |
| Montereggi, A | 1 |
| Dolara, A | 1 |
| Alexopoulos, G | 1 |
| Karli, JN | 1 |
| Margari, ZJ | 1 |
| Agapitos, E | 1 |
| Patsi, EN | 1 |
| Stamatelopoulos, SF | 1 |
| Suwa, M | 1 |
| Kasama, S | 1 |
| Toyama, T | 1 |
| Hoshizaki, H | 1 |
| Oshima, S | 1 |
| Taniguchi, K | 1 |
| Iwasaki, T | 1 |
| Nagai, R | 1 |
| Bänsch, D | 1 |
| Böcker, D | 1 |
| Brunn, J | 1 |
| Weber, M | 1 |
| Breithardt, G | 1 |
| Block, M | 1 |
| SoRelle, R | 1 |
| Nakajima, M | 1 |
| Kawahara, Y | 1 |
| Yoshida, K | 1 |
| Miyashita, N | 1 |
| Niki, Y | 1 |
| Matsushima, T | 1 |
| Kuga, K | 1 |
| Weissel, M | 1 |
| Silvetti, MS | 1 |
| Drago, F | 1 |
| Bevilacqua, M | 1 |
| Ragonese, P | 1 |
| Matsuyama, T | 1 |
| Tanno, K | 1 |
| Obara, C | 1 |
| Ryu, S | 1 |
| Adachi, T | 1 |
| Ezumi, H | 1 |
| Asano, T | 1 |
| Miyata, A | 1 |
| Koba, S | 1 |
| Baba, T | 1 |
| Katagiri, T | 1 |
| Alter, P | 1 |
| Marketou, ME | 1 |
| Simantirakis, EN | 1 |
| Manios, EG | 1 |
| Vardas, PE | 1 |
| Katsivas, AG | 1 |
| Vassilopoulos, C | 1 |
| Tsatiris, CG | 1 |
| Valensise, H | 1 |
| Civitella, C | 1 |
| Garzetti, GG | 1 |
| Romanini, C | 1 |
| Sternick, EB | 1 |
| Bahia, FC | 1 |
| Gontijo Filho, B | 1 |
| Vrandecic, MO | 1 |
| Brakhmann, I | 1 |
| Shmitt, K | 1 |
| Baĭer, T | 1 |
| Valdeker, B | 1 |
| Khilbel, T | 1 |
| Kiubler, V | 1 |
| Zirm, B | 1 |
| Zirm, A | 1 |
| Kargl, R | 1 |
| Hartter, E | 1 |
| Faber, T | 1 |
| Furtwängler, A | 1 |
| Meinertz, T | 1 |
| Goedel-Meinen, L | 3 |
| Hofmann, M | 2 |
| Schmidt, G | 3 |
| Maier-Rudolph, W | 2 |
| Barthel, P | 2 |
| Schrag, A | 2 |
| Baedeker, W | 3 |
| Blömer, H | 3 |
| Ciszewski, A | 1 |
| Bilińska, ZT | 1 |
| Lubiszewska, B | 1 |
| Popławska, W | 1 |
| Michalak, E | 1 |
| Walczak, F | 1 |
| Ruzyłło, W | 1 |
| Arbustini, E | 1 |
| Grasso, M | 1 |
| Salerno, JA | 1 |
| Gavazzi, A | 1 |
| Pucci, A | 1 |
| Bramerio, M | 1 |
| Calligaro, A | 1 |
| Ferrans, VJ | 1 |
| Keogh, AM | 1 |
| Baron, DW | 1 |
| Hickie, JB | 1 |
| Terra-Filho, M | 1 |
| Vargas, FS | 1 |
| Meneguetti, JC | 1 |
| Soares Júnior, J | 1 |
| Cukier, A | 1 |
| Teixeira, LR | 1 |
| Camargo, EE | 1 |
| Santini, M | 1 |
| Ansalone, G | 1 |
| Cacciatore, G | 1 |
| Di Marcotullio, G | 1 |
| Carelli, M | 1 |
| Tubaro, M | 1 |
| Alexidou, G | 1 |
| Bisceglie, I | 1 |
| Best, JF | 1 |
| Rinkenberger, R | 1 |
| Lynch, L | 1 |
| Dunn, M | 1 |
| Antonelli Incalzi, R | 1 |
| Gemma, A | 1 |
| Frustaci, A | 1 |
| Rossi, E | 1 |
| Carbonin, PU | 1 |
| Jahns, G | 1 |
| Klein, G | 1 |
| Wirtzfeld, A | 1 |
| McKenna, WJ | 1 |
| Cleland, JG | 1 |
| Dargie, HJ | 1 |
| Peters, KG | 1 |
| Kienzle, MG | 1 |
| Mestroni, L | 2 |
| Miani, D | 1 |
| Neri, R | 2 |
| Camerini, F | 2 |
| Gol'dberg, GA | 1 |
| Ermakova, EN | 1 |
| Shakhshneĭder, NM | 1 |
| Tomaszewski, R | 1 |
| Rae, AP | 1 |
| Spielman, SR | 1 |
| Kutalek, SP | 1 |
| Kay, HR | 1 |
| Horowitz, LN | 1 |
| Brodsky, MA | 1 |
| Allen, BJ | 1 |
| Walker, CJ | 1 |
| Casey, TP | 1 |
| Luckett, CR | 1 |
| Henry, WL | 1 |
| Leman, RB | 1 |
| Gillette, PC | 1 |
| Zinner, AJ | 1 |
| Salvi, A | 1 |
| Pandullo, C | 1 |
| Solares, G | 1 |
| Ramos, F | 1 |
| Martín-Durán, R | 1 |
| San-José, JM | 1 |
| Buitrago, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Multi-center, Open Label, Randomised Parallel- Group Study to Compare the Efficacy of Cholestyramine Plus Standard Treatment Versus Prednisolone Plus Standard Treatment Versus Standard Treatment Alone in Treatment of Overt Hyperthyroidism[NCT03303053] | Phase 3 | 135 participants (Anticipated) | Interventional | 2017-05-11 | Recruiting | ||
| CRT-P or CRT-D in Patients With Dilated Cardiomyopathy and Heart Failure Without LGE-CMR High-risk Markers[NCT04139460] | 924 participants (Anticipated) | Interventional | 2020-06-30 | Not yet recruiting | |||
| Double Sequence External Defibrillation: A Randomized Controlled Trial in Patients With Atrial Fibrillation Refractory to DC Cardioversion[NCT03827915] | 100 participants (Anticipated) | Interventional | 2019-01-21 | Recruiting | |||
| Modeling of Amiodarone Effect on Heart Rate Control in Critically Ill Patients With Atrial Tachyarrhythmias[NCT03413150] | 80 participants (Actual) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for amiodarone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Drug Inter | 2017 |
Thyrotoxic cardiac disease.
Topics: Adrenergic Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Di | 2008 |
Sudden cardiac death in dilated cardiomyopathy -- therapeutic options.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, D | 2002 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
[Management of patients with risk of sudden death. The amiodarone example].
Topics: Amiodarone; Arrhythmias, Cardiac; Canada; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Europe; H | 1994 |
Sudden death prevention in patients with advanced ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Su | 1993 |
Antiarrhythmic therapy in patients with congestive heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Multicenter Studies as Topic; M | 1993 |
Evaluation and treatment of nonsustained ventricular tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomegaly; Cardiomyopathy, Dilated; Electrocardiography; Hear | 1996 |
[Medical treatment for cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2000 |
[Hyperthyroidism and heart].
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Dilated; D | 2001 |
[Dilated cardiomyopathy in children and adolescents. Diagnostic problems, clinical course and prognosis].
Topics: Adolescent; Amiodarone; Cardiomyopathy, Dilated; Child; Child, Preschool; Digoxin; Echocardiography; | 1991 |
[Disorders of cardiac rhythm and conduction in Chagas cardiomyopathy].
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Chagas Cardiomyopathy; Humans | 1986 |
16 trials available for amiodarone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Costs and Cost Analysis; Defibrillators | 2003 |
Are implantable cardioverter-defribrillators always superior to amiodarone?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Cost-Benefi | 2003 |
Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2003 |
Effect of biventricular pacing therapy in patients with dilated cardiomyopathy with severe congestive heart failure.
Topics: Administration, Oral; Aged; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiomyopa | 2004 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobut | 2006 |
Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Beverages; Cardiomyopathy, Dilated; | 2008 |
[Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
Topics: Administration, Oral; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Deat | 1996 |
Effects of amiodarone on tumor necrosis factor-alpha levels in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Biomarkers; Cardiomyopathy, Dilated; Double-Blind Method; | 1999 |
Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Chi-Square Dis | 1999 |
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; | 1992 |
[Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Death, Sudden, Cardiac; Electrocardiography; Femal | 1992 |
Pulmonary clearance of technetium 99m diethylene triamine penta-acetic acid aerosol in patients with amiodarone pneumonitis.
Topics: Aerosols; Amiodarone; Cardiomyopathy, Dilated; Diagnosis, Differential; Female; Heart Failure; Human | 1990 |
Antiarrhythmic drugs in advanced organic heart disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Dise | 1986 |
Ventricular arrhythmias in heart failure; their significance and modification by amiodarone (with notes on the safety of combined therapy with captopril).
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Captopril; Cardiomyopathy, Dilated; Clinical Tr | 1986 |
[Effect of the intravenous administration of cordarone on the functional state of the cardiovascular system and the value of the supplementary use of corinfar].
Topics: Amiodarone; Benzofurans; Cardiomyopathy, Dilated; Clinical Trials as Topic; Double-Blind Method; Dru | 1986 |
Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated | 1987 |
80 other studies available for amiodarone and Cardiomyopathy, Dilated
| Article | Year |
|---|---|
A Young Man With Wide Complex Tachycardia-The Devil Is in the Details.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiomyopathy, Dilated; Defibrillators, Im | 2021 |
Clinical Outcomes in Patients With Dilated Cardiomyopathy and Ventricular Tachycardia.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Catheter Ablation; Female; Humans; Male; Middle Aged; Rec | 2022 |
Functional recovery of cardiomyopathy induced by atrial tachycardia in children: Insight from cardiac strain imaging.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Case-Contr | 2021 |
Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Delayed Diagnosis; Female; Grave | 2021 |
Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis.
Topics: Alstrom Syndrome; Amiodarone; Cardiomyopathy, Dilated; Diabetes Mellitus, Type 2; Female; Humans; Ki | 2022 |
[Severe ventricular arrhythmias in a patient with dilated cardiomyopathy and automated implantable defibrillator (AID)].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Death, Sudden, Ca | 2017 |
Cardiac manifestations in Emery-Dreifuss muscular dystrophy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Ele | 2018 |
Proarrhythmic effect of 'Reverse Mode Switch' in a patient with dilated cardiomyopathy and drug-induced long QTc interval.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy; Cardiac Resynchronizati | 2015 |
Cat's whiskers & corneal verticillata secondary to amiodarone intake.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Cataract; Dose-Response Relationship, Drug; Humans; Male; | 2015 |
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin- | 2017 |
[Predictive parameters of occurrence of adequate interventions in patients with implanted cardioverter-defibrillators with or without resynchronisation therapy in primary prevention of sudden cardiac death in dilated cardiomyopathy].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Resynchronization Therapy; C | 2017 |
Severe left ventricular dysfunction in infants with ventricular preexcitation.
Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilate | 2008 |
[Immediate and late results of combined treatment of dilatated cardiomyopathy in children].
Topics: Adolescent; Amiodarone; Cardiomyopathy, Dilated; Child; Child, Preschool; Disease Progression; Femal | 2008 |
Short-term amiodarone treatment attenuates the production of monocyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultur | 2009 |
Does anti-inflammatory action of amiodarone explain the high efficacy in patients with heart failure?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; C-Reactive Protein; Cardiomyopathy, Dilated; Cells, Cultur | 2009 |
Fetal dilated cardiomyopathy caused by persistent junctional reciprocating tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Blood Flow Velocity; Cardiomyopathy, Dilated; Digoxin; Dr | 2009 |
Combined amiodarone and low-dose carvedilol treatment for severe heart failure in childhood.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Dos | 2010 |
Interactive medical case. The beat goes on.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Bundle-Branch Block; Cardiomyopathy, Dilated; Def | 2010 |
Proarrhythmic potential of amiodarone: an underestimated risk?
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated | 2012 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Def | 2011 |
Role of defibrillation threshold testing in the contemporary defibrillator patient population.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathy, | 2013 |
Hemodynamics during chronic amiodarone administration in Japanese patients with idiopathic dilated cardiomyopathy and ventricular arrhythmia: a retrospective study.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Drug Administration Schedu | 2003 |
[Arrhythmogenic dilated cardiomyopathy].
Topics: Adult; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Anticoagulants; | 2003 |
Rapidly fatal acute amiodarone hepatitis occurring in the context of multiple organ failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Dilated; Chemical and Drug | 2003 |
Clinical trials of prophylactic implantable defibrillator therapy in patients with nonischemic cardiomyopathy: what have we learned and what can we expect from future trials?
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 2003 |
Amiodarone versus implantable cardioverter defibrillator for asymptomatic nonsustained ventricular tachycardia in nonischemic dilated cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Evidence-B | 2004 |
Simultaneous double external DC shock technique for refractory atrial fibrillation in concomitant heart disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Dilated; Cardiomyopat | 2004 |
Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Amiodarone; Animals; Blood Pressure; Cardiomyopathy, Dilated; Cytokines; Dise | 2005 |
The long-term survival benefit conferred by intermittent dobutamine infusions and oral amiodarone is greater in patients with idiopathic dilated cardiomyopathy than with ischemic heart disease.
Topics: Administration, Oral; Aged; Amiodarone; Cardiomyopathy, Dilated; Dobutamine; Female; Hemodynamics; H | 2006 |
[Use of lithium carbonate for the treatment of amiodarone-induced thyrotoxicosis].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Cardiomyopathy, Dilated; Heart Transp | 2005 |
Paroxysmal atrial fibrillation precipitated by amiodarone-induced thyrotoxicosis five months after cessation of therapy.
Topics: Amiodarone; Atrial Fibrillation; Cardiomyopathy, Dilated; Electrocardiography; Humans; Male; Middle | 2006 |
[Interstitial pneumonitis followed by syndrome of inappropriate antidiuretic hormone secretion induced by amiodarone therapy for dilated cardiomyopathy: a case report].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Humans; Inappropriat | 2006 |
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.
Topics: Aged; Amiodarone; Anesthesia, Local; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autonomic Nerve B | 2007 |
Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: long term follow-up.
Topics: Adrenergic beta-Antagonists; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Femal | 2006 |
Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Defibrillators, I | 2006 |
Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Body Mass Index; Cardiomyopathy | 2006 |
[Cardioversion of amiodarone-insensitive atrial fibrillation by bepridil in heart failure: two case reports].
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Cardiomy | 2006 |
Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy, Dilated; Digoxin; Dr | 2007 |
[Combined therapy with weight loss and amiodarone improved cardiac function in a patient with idiopathic dilated cardiomyopathy complicated with severe obesity: a case report].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Body Mass Index; Cardiomyopathy, Dilated; Diet, Reducing; | 2007 |
Thyroid hormone is a critical determinant of myocardial performance in patients with heart failure: potential therapeutic implications.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Exercise Test; Female; Forced Ex | 2007 |
Digoxin toxicity associated with amiodarone therapy in children.
Topics: Adolescent; Amiodarone; Benzofurans; Cardiomyopathy, Dilated; Child; Child, Preschool; Creatinine; D | 1984 |
Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Death, Sudden; Electric St | 1984 |
Amiodarone for ventricular tachycardia after coronary artery bypass grafting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Artery Bypass; Humans; Infusio | 1995 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinati | 1994 |
Is there an effect of amiodarone on the defibrillation threshold?
Topics: Adult; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Humans | 1993 |
[Implantation of a transvenous defibrillation system in isolated persistent left superior vena cava].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Coronary Angiography; Defibrillators, I | 1997 |
Circadian modulation of ventricular tachycardia cycle length variability in ICD patients with dilated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Circadian Rhythm; Defibrillators, | 1997 |
Reversible high rate atrial fibrillation dilated cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathy | 1997 |
Management of incessant ventricular tachycardia in a 39-year-old woman with cardiomyopathy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Critical Illness; Defibrillators | 1997 |
[Effect of chronic amiodarone therapy on left ventricular function in dilated cardiomyopathy studied by the new Doppler-index].
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Dose-Response Relationship, Drug; Echo | 1998 |
Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Disease Pro | 1998 |
Amiodarone concentration in human myocardium after rapid intravenous administration.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Body Weight; Cardiomyopathy, Dilated; Female; Fibro | 1999 |
[Prediction of cardiac sympathetic nerve activity and cardiac functional outcome after treatment in patients with dilated cardiomyopathy: examination using dobutamine gated blood pool scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibi | 2000 |
Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Hear | 2000 |
Cardiovascular news. AMIOVIRT.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Defibrillator | 2000 |
Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antigens; Antigens, Neoplasm; Biomarkers; Carbon Monoxide; Cardi | 2000 |
Torsade de pointes induced by intravenous and long-term oral amiodarone therapy in a patient with dilated cardiomyopathy.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Electrocard | 2001 |
Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Child; Dose-Respo | 2001 |
T wave alternans for predicting adverse effects of amiodarone in a patient with dilated cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocar | 2001 |
[Amiodarone induced pulmonary toxicity].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Humans; Long-Term Care; Male; Pneumonia; Pulmonary | 2002 |
Electrical storm due to amiodarone induced thyrotoxicosis in a young adult with dilated cardiomyopathy: thyroidectomy as the treatment of choice.
Topics: Adult; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Female; Humans; Tachycardia | 2001 |
Electrical storms in an ICD-recipient with 429 delivered appropriate shocks: therapeutic management with antiarrhythmic drug combination.
Topics: Aged; Amiodarone; Cardiomyopathy, Dilated; Defibrillators, Implantable; Electrocardiography; Follow- | 2002 |
Amiodarone treatment in pregnancy for dilatative cardiomyopathy with ventricular malignant extrasystole and normal maternal and neonatal outcome.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; Echo | 1992 |
[Cardiomyopathy induced by incessant ventricular tachycardia ("tachycardiomyopathy"): cure after control of arrhythmia].
Topics: Amiodarone; Cardiomyopathy, Dilated; Child; Electrocardiography; Heart Rate; Humans; Male; Tachycard | 1992 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; C | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor | 1992 |
[Effect of amiodarone on signal-averaged and long-term ECG].
Topics: Aged; Aged, 80 and over; Amiodarone; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardi | 1991 |
Endomyocardial biopsy finding in two patients with idiopathic dilated cardiomyopathy receiving long-term treatment with amiodarone.
Topics: Amiodarone; Cardiomyopathy, Dilated; Female; Humans; Male; Middle Aged; Myocardium | 1991 |
Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation.
Topics: Adolescent; Adult; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; | 1990 |
Amiodarone--efficacy and late potentials during long-term therapy.
Topics: Amiodarone; Cardiomyopathy, Dilated; Coronary Disease; Electrocardiography; Humans; Prospective Stud | 1990 |
[Endocavitary transcatheter electric fulguration as a therapeutic alternative in refractory ventricular tachycardia].
Topics: Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Catheterization; Electrosurgery; Follow-Up Studies | 1990 |
Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
Topics: Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Complexes, Premature; Cardiomyopathy, Dilated; | 1986 |
Low atrial tachycardia as primary cause of the heart failure complicating congestive cardiomyopathy.
Topics: Amiodarone; Cardiomyopathy, Dilated; Electrocardiography; Hemodynamics; Humans; Male; Middle Aged; T | 1989 |
Amiodarone and the cardiomyopathies.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathies; Cardiomyopathy, Dilated; Car | 1986 |
Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm.
Topics: Amiodarone; Atrial Fibrillation; Cardiomyopathy, Dilated; Chronic Disease; Electrocardiography; Hear | 1988 |
[Ambulatory ECG in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiomyopathy, Dilated; | 1987 |
Amiodarone for maintenance of sinus rhythm after conversion of atrial fibrillation in the setting of a dilated left atrium.
Topics: Adult; Aged; Amiodarone; Atrial Fibrillation; Cardiomyopathy, Dilated; Female; Heart Atria; Heart Va | 1987 |
Resolution of congestive cardiomyopathy caused by supraventricular tachycardia using amiodarone.
Topics: Adult; Amiodarone; Benzofurans; Cardiomyopathy, Dilated; Female; Humans; Tachycardia | 1986 |
Ventricular arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathy, D | 1987 |
Amiodarone, phaeochromocytoma and cardiomyopathy.
Topics: Adrenal Gland Neoplasms; Aged; Amiodarone; Anesthesia, General; Arrhythmias, Cardiac; Benzofurans; C | 1986 |